Score Overview
Maravai Lifesciences Holdings Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 284M to $ 185M and net income went from $ 76M to -$ 130M. Revenue increased in 2 of those 5 years; net income in 3.
Maravai Lifesciences Holdings Inc currently holds a 5-year HDB Score of 3.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 5.78 | — |
1 Year2025-08-12 | $ 2.69 | 114.87% |
5 Years2021-08-12 | $ 55.12 | -89.51% |
All Time2020-11-20 | $ 29.85 | -80.64% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-11-20 |
|---|---|---|---|---|
| Price | $ 5.78 | $ 2.69 | $ 55.12 | $ 29.85 |
| Return | — | 114.87% | -89.51% | -80.64% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 208M | -$ 77M | $ 70M |
| 2025 | $ 185M | -$ 130M | $ 216M |
| 2024 | $ 259M | -$ 144M | $ 322M |
| 2023 | $ 288M | -$ 119M | $ 574M |
| 2022 | $ 883M | $ 220M | $ 632M |
| 2021 | $ 799M | $ 182M | $ 551M |
| IPO2020 | $ 284M | $ 76M | $ 236M |
Explore beyond MRVI
You're looking at Maravai Lifesciences Holdings Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
